UNDERUTILIZATION OF MAGNESIUM SULFATE CASE OF THE KENITRA PROVINCE BETWEEN 2010 AND 2014
Journal Title: World Journal of Pharmaceutical and Medical Research - Year 2018, Vol 4, Issue 12
Abstract
Background: If eclampsia is the second direct cause of maternal deaths in the international and national levels, Kenitra made except by recording this complication as a leading cause of maternal deaths in the province, with a percentage of 42.9%. An alarming figure that intersects with an underutilization of magnesium sulfate (SO4Mg), despite its importance in improving the health status of pre-eclamptic and eclamptic women. The objective of this work: Describe the factors associated with the underutilization of magnesium sulfate by midwives, nurse midwife and doctors from the six birthing centers in Kenitra province during the 2010-2014 period. Materials and Methods: With exhaustive sampling, this study used two measuring instruments. On the one hand, a self-administered questionnaire with 32 people, with a response rate of 100%. On the other hand, interviews with a responsible of the reference maternity of kenitra, a resuscitator of the provincial hospital, and a resource person at the network of basic health care in Kenitra. Results: According to the results of this study, 71.43% of participants do not use magnesium sulfate, against only 28.57% who use it. And among those they use 38.10% reported their dissatisfaction with its use. This is due to a number of factors: a) team dynamics and interpersonal relationships that occurred in 52.38% of responses. b) The need for quality continuing education raised by 52.38%. c) The perception of magnesium sulfate as a danger illustrated in 80.95%. d) The fear of this drug noted in 61, 90%. e) The medico-legal reasons identified in 61.91% of the answers as factors in the non-use of magnesium sulfate. f) The non-existence of a law authorizing its use in 95.24%. g) The legal framework for the practice of midwives in 85.72%. h) The risk of legal proceedings reported by 61.91%. i) The effective of staff is recorded in 80.95%. j) The working conditions raised at 71, 43%. k) The non-involvement of doctors in the decision to use this drug in 66.67%. l) The quality of communication between the delivery house and the reference maternity in 52.38% And, m) transfer barriers advanced by 71.43% of participants in this study. Conclusion: Since magnesium sulfate is an effective therapeutic that is at the forefront of anticonvulsants, the results of this study demonstrate the need to federate the government and local efforts to deal with its underutilization.
Authors and Affiliations
Asmaa Barkat
Keywords
Related Articles
- EP ID EP666048
- DOI -
- Views 168
- Downloads 0
UNDERUTILIZATION OF MAGNESIUM SULFATE CASE OF THE KENITRA PROVINCE BETWEEN 2010 AND 2014
Background: If eclampsia is the second direct cause of maternal deaths in the international and national levels, Kenitra made except by recording this complication as a leading cause of maternal deaths in the province, w...
PREVALENCE AND PROGRESSION OF DIABETIC RETINOPATHY IN PATIENTS NEWLY DIAGNOSED WITH TYPE 2 DIABETES MELLITUS
Context: Many diabetic patients fear visual loss as the worst consequence of diabetes. In most studies the main eye pathology is assigned as the cause of visual impairment. Diabetic retinopathy, the most frequent cause o...
ASSOCIATION LUPUS AND TUBEROUS SCLEROSIS: IS IT POSSIBLE? THE INVOLVEMENT OF MTOR PATHEWAY
Tuberous sclerosis is an autosomal dominant disorder characterized by involvement of skin, nervous system, kidneys, and lungs. It results from mutations in 1 of 2 genes: TSC1 (encoding hamartin) or TSC2 (encoding tuberin...
BULLOUS PEMPHIGOID - A CASE REPORT
Bullous pemphigoid is a blistering eruption characterized by large, tense bullae on the flexor surfaces, trunk, and intertriginous regions. Bullae may arise on an inflammatory urticarial base or on previously normal skin...
A STUDY REGARDING EFFICACY OF RIFAXIMIN IN HEPATIC ENCEPHALOPATHY DUE TO LIVER CIRRHOSIS
Background: Hepatic encephalopathy is the second most common major complication in cirrhotic patients and it significantly impacts quality of life. Medicinal approaches for hepatic encephalopathy treatment and prevention...